Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Express Scripts
Chinese Patent Office
AstraZeneca
Chubb
Daiichi Sankyo
Cerilliant
UBS
Medtronic

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202010

« Back to Dashboard

NDA 202010 describes TAMSULOSIN HYDROCHLORIDE, which is a drug marketed by Anchen Pharms, Aurobindo Pharma Ltd, Impax Labs, Macleods Pharms Ltd, Mylan, Sandoz, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Wockhardt, Zydus Pharms Usa Inc, and Alkem Labs Ltd, and is included in twelve NDAs. It is available from fifty-one suppliers. Additional details are available on the TAMSULOSIN HYDROCHLORIDE profile page.

The generic ingredient in TAMSULOSIN HYDROCHLORIDE is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.
Summary for 202010
Tradename:TAMSULOSIN HYDROCHLORIDE
Applicant:Anchen Pharms
Ingredient:tamsulosin hydrochloride
Patents:0
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202010
Mechanism of ActionAdrenergic alpha-Antagonists
Suppliers and Packaging for NDA: 202010
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 202010 ANDA Par Pharmaceutical, Inc. 10370-169 N 10370-169-01
TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 202010 ANDA Par Pharmaceutical, Inc. 10370-169 N 10370-169-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.4MG
Approval Date:Jan 4, 2013TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Healthtrust
Covington
AstraZeneca
Deloitte
Argus Health
US Department of Justice
Chubb
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.